New biomarker highly promising for predicting breast cancer outcomes
Tuesday, August 26, 2014 - 04:00
in Health & Medicine
A protein named p66ShcA shows promise as a biomarker to identify breast cancers with poor prognoses, according to research. The ability to predict prognosis is critical to management of treatment. A patient with a good prognosis can be spared aggressive treatment, with its oft-unpleasant side effects. But failure to apply aggressive treatment to an aggressive tumor can lead to death.